COVID-19 Response: Unprecedented Opportunities In Digital Health & Biotech

Join us on May 19th where experts in the field of medicine, biotech, and investing will focus on two areas of unprecedented opportunity given the current pandemic: The desperate need and requirement for digital health as well as fast-tracking drug commercialization.

Topics include:

  • Digital health solutions for business and personal medical status certification

  • New business lines including potential digital immunity passports

  • Ethical and technical landscape of Identity, Privacy, Track and trace

  • Advancing investment in AI-directed drug therapies

  • The expansion of Emergency Use Approvals

  • Unprecedented time and cost to market modifications driving investment

Previous
Previous

Webcast: Funding Innovation

Next
Next

AI May Be Used to Find New Cures in Old Drugs